Vendor, Souderton, PA
Hemoglobin Oxygen Therapeutics LLC
UEI UJAMF5FC81N9, CAGE 7NSG9
1 award and $9,559,948 obligated between May 22, 2025 and March 16, 2026, 0% under full and open competition, against 1.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $9,559,948 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Notice of Intent to Sole Source: Canine Oxygen Carrier Manufacturing Restoration and Regulatory Activities
Defense Health Agency (Dha), Army Med Res Acq Activity
Award noticeNAICS 541715Frederick, MDHT942525C0035Awarded to Hemoglobin Oxygen Therapeutics LLC for $12,534,579
Posted May 28, 2025
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942525C0035Definitive Contract, May 22, 2025, Not Competed, 1 offersSolicitation | Army Med Res Acq ActivityDefense Health Agency | Canine Oxygen Carrier Manufacturing Restoration and Regulatory ActivitiesNAICS 541715, PSC AN13 | $9,559,948 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 6 across 1 awards